Patent ES-8603186-A1 (ES)
Title: Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents.
IPC: C07D473/00
Filed: 1985-07-16
Abstract: 8-(R1O-CH2-CH(-CH2-OR2)-O-CH2) -1-R5-1-R6-2-R4-3-R3-purine derivs. of formula (I) and intermediates (XV) are new (where R1 is H, -CY-OR7 or -CO-NHR7 R7 is 1-12C alkyl, 2-12C alkenyl, cyclopentyl, cyclohexyl, phenyl or benzyl R2 is -CY-OR7 or -CO-NHR7 Y is O or S R3 is H, halo, mercapto, 1-6C alkylthio, azido, -NR9R10 or -NH-CO-R8 R9, R10 independently are H or 1-6C alkyl R8 is H, 1-19C alkyl or 1-adamantyl and (a) R6 is H, halo, 1-6C alkoxy, azido, mercapto, 1-6C alkylthio, -NR9R10 or -NH-CO-R8 and R4 together with R5 form a bond or (b) R5 and R6 together are oxo and R4 is H W is H or 1-carbonylimidazole and W1 is H or 1-thiocarbonylimidazole and W1 is thio-imidazole. - Antivirals with excellent activity against Herpes simplex virus I and II and related viruses, such as cytomegalovirus, Epstein-Barr virus and varicella Zoster virus. The cpds. may be administered orally, parenterally, topically, rectally or intranasally e.g. at dose levels of 0.1-300 mg/kg, pref. 1.0-30 mg/kg. They may be used to treat non-human virus infections, e.g. in chickens, turkeys, fish etc. They are active against Sciruid herpes-virus 1, Car lid herpesvirus 1, Lagomorph herpesvirus 1, Phasianid herpes virus 1 and 2 (Marek's disease), Turkey herpesvirus 1, Anatid herpesvirus 1, Catfish herpes virus 1, Equid herpes-virus 1, 2 and 3, Bovid herpes virus 1, 2, 3 and 4, Rig herpes-virus 1 and 2, Marid herpes-virus 1, Cebid herpes-viruses 1 and 2, Tupaiid herpes-virus 1, Canine herpes-virus 1 and Feline herpes-virus 1. Fish viruses treated include channel catfish virus, herpes-virus salomones and Nerka virus. EPAB- EP-105135 B A compound of the formula (I) wherein R1 is hydrogen, -C(Y)OR7 or -C(O)NHR7 wherein R7 is alkyl of one to twelve carbon atoms, alkenyl of two to twelve carbon atoms, cyclopentyl, cyclohexyl, phenyl or benzyl R2 is -C(Y)OR7 or -C(O)NHR7 wherein R7 is as defined above Y is oxygen or sulfur R3 is hydrogen, halo, thio, alkylthio of one to six carbon atoms, azido, NR9R10 wherein R9 and R10 are independently hydrogen or alkyl of one to six carbon atoms or -NHC(O)R8 wherein R8 is hydrogen, alkyl of one to nineteen carbon atoms of 1-adamantyl and (a) R6 is hydrogen, halo, alkoxy of one to six carbon atoms, azido, thio, alkylthio of one to six carbon atoms, -NR9R10 wherein R9 and R10 are as defined as above or -NHC(O)R8 wherein R8 is ad defined above and R4 together with R5 is a bond or (b) R5 together with R6 is keto group and R4 is hydrogen. USAB- US4609661 A Substd. 9-(1-O- or 3-O-monosubstd. or 1,3-di-O-substd. propoxymethyl purines of formula (I) are new. In (I), W is H or 1-carbonyl imidazole and Wa is 1-carbonyl imidazole or W is H or 1-thiocarbonyl imidazole and Wa is 1-thiocarbonylimidazole: R3 is H, halo, thio, 1-6Calkylthio azido NR9R10 with R9 and R10 each H, 1-6Calkyl or NHC(O)R8 with R8 is H, 1-19Calkyl or 1-adamantile and a R6 is H, halo, 1-6C-alkoxy or -alkylthio, azido, thio, NR9R10 R5 and R6 together form a bond or b R5 and R6 together are keto with R4 is H. - (I) may be prepd. e.g. by reacting dihydroxy cpd. (X) or (XIV) in which A is H with dicarbonate (R7OC(O))2O or new intermediate (XV) with appropriate alcohol or amine.